BioCentury
ARTICLE | Financial News

Obalon Therapeutics completes IPO

October 10, 2016 7:00 AM UTC

Obalon Therapeutics Inc. (NASDAQ:OBLN), Carlsbad, Calif. Business: Endocrine/Metabolic Date completed: 2016-10-05 Type: IPO Raised: $75 million Shares: 5 million Price: $15 Shares after offering: 16 m...